LOUISVILLE, CO, January 19, 2010 – GlobeImmune Inc., a company developing novel therapies for patients with cancer and infectious diseases, today announced a Series E Preferred Stock financing of $17.5 million. The round was led by new investors Generali Financial … Continue reading
GlobeImmune Announces $17.5 Million Series E Financing
January 19, 2010